Gene-Edited Babies: The UK Just Made History

#shorts #sickle-cell disease #beta-thalassemia #hemoglobin #CRISPR Sickle-cell disease and beta-thalassemia patients in the UK rejoice!** The world’s first CRISPR-based therapy has been approved by the UK medicines regulator, meaning that these two blood conditions could soon be a thing of the past. The treatment, called CASGEVY, uses CRISPR to edit a gene that normally prevents production of a type of fetal hemoglobin. This allows the body to produce hemoglobin that is free of the abnormalities associated with sickle-cell disease and beta-thalassemia, which in turn boosts oxygen supply to the tissues and alleviates patients’ symptoms. Of course, this is not a cure-all – the treatment is expensive and only available to patients aged 12 and up. But it’s a huge step forward in the fight against these devastating diseases, and we can’t wait to see what CRISPR can do next.

👋 Feeling the vibes?

Keep the good energy going by checking out my Amazon affiliate link for some cool finds! 🛍️

If not, consider contributing to my caffeine supply at Buy Me a Coffee ☕️.

Your clicks = cosmic support for more awesome content! 🚀🌈